ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera

Detalles Bibliográficos
Autores principales: Guglielmelli, Paola, Coltro, Giacomo, Mannelli, Francesco, Rotunno, Giada, Loscocco, Giuseppe G., Mannarelli, Carmela, Maccari, Chiara, Paoli, Chiara, Romagnoli, Simone, Bartalucci, Niccolò, Vannucchi, Alessandro M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092422/
https://www.ncbi.nlm.nih.gov/pubmed/35020812
http://dx.doi.org/10.1182/bloodadvances.2021006350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092422/
https://www.ncbi.nlm.nih.gov/pubmed/35020812
http://dx.doi.org/10.1182/bloodadvances.2021006350

Ejemplares similares